This news is being reposted e.g. here and maybe just reaching awareness of more investors and hedge funds who allegedly dumped some biotechs @end of quarter to look better on their balance sheets.
Big deal, working in tandem with NCI, they wouldn't choose Galina if it were likely to fail:
Posted: Wed, 30 Sep. 2015, 08:57:41 -0400
Ticker: GALE
InvestmentType: Speculative
News: Galena Biopharma, Inc. - collaboration with the National Cancer Institute [NCI] to initiate a new, Phase 2 clinical trial with NeuVax™ (nelipepimut-S) in patients diagnosed with Ductal Carcinoma in Situ (DCIS) this year.
Hope the rally stays this time, today $1.74, nice climb from $1.34 last week where it plunged for no reason but manipulation in anticipation of news -- maybe that's where hedge funds wanted to buy back in for 4th quarter.
